Home Diagnostics, Inc. is a leading pure-play manufacturer and marketer in the rapidly growing $7 billion diabetes testing supplies market. The Company's innovative products are uniquely positioned to capitalize on several distribution models and gain market share with competitive price points. National pharmacy chains, distributors and managed care providers choose to co-brand with Home Diagnostics because its affordable, high-performance products deliver significant savings to these distributors and their customers.

Recent Financial Releases

May 6, 2008
Home Diagnostics Reports First Quarter 2008 Financial Results

Apr 29, 2008
Home Diagnostics to Present at Deutsche Bank 33rd Annual Health Care Conference

View all financial releases »

View all company news

Investor Relations Contact
Nick Laudico
The Ruth Group
646-536-7030
nlaudico@theruthgroup.com